Please assess the completion status of the following clinical trial:

Trial Title: Idiopathic Anemia of Aging (IAA)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 70 years of age or older~* Diagnosed with anemia~* Hemoglobin level less than or equal to 11~* Able to perform most activities of daily living without restriction~Exclusion Criteria:~* History of serious heart, liver or kidney disease~* Cancer treated within the last year except for skin cancer (excluding melanoma)~* Problems with your immune system~* Received Epoetin Alfa within the last year

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).